Manuscripts
Showing 1530 manuscripts.
Raltegravir (RAL) in Neonates: Dosing, Pharmacokinetics (PK), and Safety in HIV-1-Exposed Neonates at Risk of Infection (IMPAACT P1110)
Citation
Diana Clarke, Edward Acosta, Mae Cababasay, Jiajia Wang, Anne Chain, Hedy Teppler, Stephanie Popson, Bobbie Graham, Betsy Smith, Rohan Hazra, Kat Calabrese, Yvonne Bryson, Stephen Spector, Jos Lommerse, Mark Mirochnick, IMPAACT P1110 Protocol Team. Raltegravir (RAL) in Neonates: Dosing, Pharmacokinetics (PK), and Safety in HIV-1-Exposed Neonates at Risk of Infection (IMPAACT P1110). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 2020. 84: 70-7. PMID: 31913995Year
2020
Journal
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Study
P1110
Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial
Citation
Esaú C João, R Leavitt Morrison, David E Shapiro, Nahida Chakhtoura, Maria Isabel S Gouvèa, Maria de Lourdes B Teixeira, Trevon L Fuller, Blandina T Mmbaga, James S Ngocho, Boniface N Njau, Avy Violari, Ruth Mathiba, Zaakirah Essack , Jose Henrique S Pilotto, Luis Felipe Moreira, Maria Jose Rolon, Pedro Cahn, Sinart Prommas , Timothy R Cressey, Kulkanya Chokephaibulkit, Peerawong Werarak, Lauren Laimon, Roslyn Hennessy , Lisa M Frenkel , Patricia Anthony, Brookie M Best, George K Siberry, Mark Mirochnick. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial. Lancet HIV. 2020. 7: e322-e331. PMID: 32386720Year
2020
Journal
Lancet HIV
Study
P1081
Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study
Citation
Rolando M Viani, Theodore Ruel, Carmelita Alvero, Terry Fenton, Edward P Acosta, Rohan Hazra, Ellen Townley, Paul Palumbo, Ann M Buchanan, Cindy Vavro, Rajendra Singh, Bobbie Graham, Patricia Anthony, Kathleen George, Andrew Wiznia, P1093 Study Team. Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study. Journal of the Pediatric Infectious Diseases Society. 2020. 9: 159-165. PMID: 30951600Year
2020
Journal
Journal of the Pediatric Infectious Diseases Society
Study
P1093
Association between caregiver depression symptoms and child executive functioning. Results from an observational study carried out in four sub-Saharan countries
Citation
I Familiar, M Chernoff, H Ruisenor-Escudero, B Laughton, C Joyce, L Fairlie, V Tichaona, P Kamthunzi, L Barlow-Mosha, B Zimmer, K McCarthy, M Boivin. Association between caregiver depression symptoms and child executive functioning. Results from an observational study carried out in four sub-Saharan countries. AIDS Care. 2020. 32: 486-494. PMID: 31462095Year
2020
Journal
AIDS Care
Study
P1104s
Darunavir Pharmacokinetics With an Increased Dose During Pregnancy
Citation
Ahizechukwu C Eke, Alice M Stek, Jiajia Wang, Regis Kreitchmann, David E Shapiro, Elizabeth Smith, Nahida Chakhtoura, Edmund V Capparelli, Mark Mirochnick, Brookie M Best, IMPAACT P1026s Protocol Team. Darunavir Pharmacokinetics With an Increased Dose During Pregnancy. Journal of Acquired Immune Deficiency Syndromes. 2020. 83: 373-380. PMID: 31923087Year
2020
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy
Citation
Ahizechukwu C Eke, Jiajia Wang , Khadija Amin, David E Shapiro , Alice Stek , Elizabeth Smith, Nahida Chakhtoura, Michael Basar, Kathleen George, Katherine M Knapp, Esaú C João, Kittipong Rungruengthanakit , Edmund Capparelli, Sandra Burchett , Mark Mirochnick , Brookie M Best, P1026s Protocol Team. Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy. Antimicrobial Agents and Chemotherapy. 2020. 64: e02260-19. PMID: 32015036Year
2020
Journal
Antimicrobial Agents and Chemotherapy
Study
P1026S
Streptococcus pneumoniae colonization in pneumococcal vaccine-naïve HIV-exposed infected and -uninfected South African children
Citation
M Nunes, S Kim, B Zeldow, A Violari, S Dittmer, H Cassim, T Thomas, N van Niekerk, M Cotton, C Mitchell, P Adrian, S Madhi on behalf of the P1041 team. Streptococcus pneumoniae colonization in pneumococcal vaccine-naïve HIV-exposed infected and -uninfected South African children. Medicine. 2020. 99: e19353. PMID: 32118776Year
2020
Journal
Medicine
Study
P1041
Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children
Citation
E McFarland, R Karron, P Muresan, C Cunningham, J Libous, C Perlowski, B Thumar, D Gnanashanmugam, J Moye, E Schappell, E Barr, V Rexroad, L Fearn, S Spector, M Aziz, M Cielo, C Beneri, A Wiznia, C Luongo, P Collins, U Buchholz, IMPAACT 2011 Study Team. Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children. Journal of Infectious Diseases. 2020. 221: 534-543. PMID: 31758177Year
2020
Journal
Journal of Infectious Diseases
Study
IMPAACT 2011
Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir
Citation
Xiaomei Liu, Jeremiah D Momper, Natella Rakhmanina, John N van den Anker, Dionna Green, Gilbert J Burckart, Brookie M Best, Mark Mirochnick, Edmund V Capparelli, André Dallmann. Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir. Journal of Clinical Pharmacology. 2020. 60: 240-255. PMID: 31489678Year
2020
Journal
Journal of Clinical Pharmacology
Study
P1026S
Antenatal Intracellular Concentrations of Tenofovir Diphosphate and Emtricitabine Triphosphate and Associations Between Tenofovir Diphosphate and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) Trial
Citation
Jim Aizire, Kristina Brooks, Mark Mirochnick, Patricia M Flynn, Kevin Butler, Jennifer J Kiser, George K Siberry, Terry Fenton, Mae Cababasay, Mary G Fowler, PROMISE Study Team. Antenatal Intracellular Concentrations of Tenofovir Diphosphate and Emtricitabine Triphosphate and Associations Between Tenofovir Diphosphate and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) Trial. Journal of Acquired Immune Deficiency Syndromes. 2020. 83: 173-180. PMID: 31929405Year
2020
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
1077BF